Remember
 
 
At SpeculatingStocks You Can Discover Stocks, Post Anonymously, and React to Posts. Login is Optional.
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

January 16, 2008

SpeculatingStocks.com Stock Pick: Replidyne, Inc. (RDYN)

Stock Price: $2.45


Replidyne, Inc. is a biopharmaceutical company focusing on discovering, developing, in-licensing, and commercializing anti-infective products. Its products include Faropenem Medoxomil, an oral antibiotic; and REP8839, an anti-infective product, which is in Phase I clinical development for the treatment of skin and wound infections comprising methicillin resistant Staphylococcus aureus.

RDYN recently provided a strategic update including restructuring and pipeline prioritization in line with strategic priorities. This came as RDYN dropped from the $6.00 level to as low as $2.05.

RDYN has just begun to turn around with a strong reversal after a three day bottom. RDYN is currently trading at a market cap of only $66.17 million with revenue in 2006 of $15.98 million.

As of November 30, 2007, Replidyne had cash assets of approximately $93 million. The company believes it has internal cash resources to support operations for at least the next two fiscal years. RDYN has a strong balance sheet with no long term debt and assets exceeding liabilities by over 12 to 1.

 
     
Untitled Document